| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.0512 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.0512 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.0559 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.1377 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.1997 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.2680 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.3020 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.3202 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.3343 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.3401 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.3706 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.3771 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.4009 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.4164 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.4188 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.4303 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.4356 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.4422 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.4669 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.4858 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5049 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5052 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5080 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5216 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5290 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5306 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5321 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5449 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5508 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5512 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5537 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5579 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5833 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5844 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.5999 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.6229 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.6301 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.6473 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.6497 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.6504 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.6527 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.6593 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.6952 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7014 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7266 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7281 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7306 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7333 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7372 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7396 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7401 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7461 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7475 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7511 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7590 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7607 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7660 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7764 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7766 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7812 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.7968 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8042 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8062 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8103 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8276 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8303 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8324 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8444 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8445 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8505 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8536 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8591 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8660 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8699 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8716 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.8798 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9064 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9222 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9274 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9298 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9399 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9447 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9468 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9468 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9534 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9555 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9585 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9659 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9674 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9675 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9683 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9831 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 0.9902 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0000 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0098 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0299 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0349 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0367 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0450 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0451 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0470 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0524 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0648 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0702 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0721 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0736 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0754 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0976 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.0997 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.1256 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.1453 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.1465 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.1675 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.1713 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.1810 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.1908 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.1994 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2033 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2051 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2103 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2135 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2156 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2157 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2500 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2529 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2628 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2739 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2784 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.2938 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3161 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3284 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3301 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3627 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3642 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3734 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3752 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3757 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3873 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3886 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3946 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.3980 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.4003 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.4240 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.4355 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.4483 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.4770 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.5001 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.5222 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.5541 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.5701 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.5703 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.5721 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.5787 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.5846 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.5872 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.6045 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.6399 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.6571 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.6647 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.6864 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.7023 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.7132 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.7304 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.7354 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.7893 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.8077 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.8925 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 1.9502 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.0339 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.0400 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.0761 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.1219 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.1588 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.1764 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.3878 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.3966 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.4084 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.4309 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.4653 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.5618 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.6917 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.7413 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 2.9180 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | bilirubin | 3.0401 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 3.0944 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | bilirubin | 3.2262 | scaled units | Low-Dose | -0.5HR |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|